Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Vor Biopharma Inc. has filed 457 SEC EDGAR filings since 10 Jul 2020

SEC filing history

Showing 226-250 of 457 matching filings.

Per page
25
Current page
10
4

4 filing

Filing date
31 Dec 2024
Reporting date
27 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2024
Reporting date
30 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-92269

SCHEDULE 13D/A filing

Filing date
30 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39979

144 filing

Filing date
27 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92269

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Nov 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Nov 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Nov 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Nov 2024
Reporting date
06 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Oct 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2024
Reporting date
03 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Sep 2024
Reporting date
01 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
08 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .